|
|||
COMMIT/CCS-2 Biographies
Dr Zhengming Chen Reader in
Epidemiology at the University of Oxford. Dr Chen qualified in
medicine in Shanghai in 1983, joining the Clinical Trial Service
Unit (CTSU) in 1987. He gained his DPhil from Oxford in 1993. He
is the director of CTSU's China programme, responsible for
several large projects in China, including trials of treatment
for vascular diseases, cancer and observational epidemiological
studies of the causes of chronic diseases. He is also the
co-executive director of the Fuwai-Oxford Collaborative Centre
for Cardiovascular Health and an honorary Professor at Peking
Union Medical College. Dr Chen is principal investigator of
COMMIT/CCS-2.
Dr Yiping Chen Senior
Research Fellow at the University of Oxford. Dr Chen qualified in
medicine in Shanghai in 1985, gained her DPhil in Oxford in 1993
and joined the CTSU in 1998. She is also co-associate director of
the Fuwai-Oxford Collaborative Centre for Cardiovascular Health,
and has been clinical co-ordinator of COMMIT/CCS-2 at the Oxford
co-ordinating centre since the beginning of the trial.
Professor Rory Collins
British Heart Foundation Professor of Medicine & Epidemiology
at the University of Oxford. In 1981, Professor Collins joined
the CTSU, and became its co-director with Professor Sir Richard
Peto in 1986. Professor Collins's work has been in the
establishment of large-scale randomised trials of the treatment
of heart disease, other vascular disease and cancer. He has also
been closely involved in developing approaches to combining
results from related trials ('meta-analyses') that allow the more
reliable assessment of treatment effects. Professor Collins is
co-director of the Fuwai-Oxford Collaborative Centre for
Cardiovascular Health, honorary Professor at Peking Union Medical
College, and co-chair of the International Steering Committee of
COMMIT/CCS-2.
Dr Lixin Jiang Associate
Professor in Fuwai Hospital, Chinese Academy of Medical Sciences.
Dr Jiang qualified in medicine in Jiangsu in 1989 and gained her
MSc at Fuwai Hospital in 1995. She co-ordinated the INTER-HEART
study of the causes of heart attacks in China, is co-associate
director of the Fuwai-Oxford Collaborative Centre for
Cardiovascular Health, and has been clinical co-ordinator of
COMMIT/CCS-2 at the Beijing co-ordinating centre since the
beginning of the trial.
Professor Lisheng Liu
Professor of Medicine in Fuwai Hospital, Chinese Academy of
Medical Sciences since 1983. Professor Liu retired from Fuwai in
2000, but continued as the director of the Clinical Trials and
Research Centre, Chinese Hypertension League. She has been
president of the Chinese Hypertension League since 1989, and is
vice-president of the World Hypertension League. She has also
been co-chair of the Scientific Steering Committee of the Global
Health Forum Cardiovascular Disease Initiative in Developing
Countries (World Health Organization) since 1999. Professor Liu
is co-chair of the International Steering Committee of
COMMIT/CCS-2.
Dr Hongchao Pan Medical
Research Council Senior Research Fellow. Dr Pan has been working
in the CTSU for ten years as a senior clinical data analyst and
computer programmer. During this time he has been involved in the
design, data management and analysis of several large-scale
randomised clinical trials and epidemiological studies in
vascular disease and cancer. He has co-authored several clinical
and epidemiological research papers published in the Lancet,
British Medical Journal, and Stroke, and a monograph on the
geographic study of mortality, biochemistry, diet and lifestyle
in rural China. Dr Pan is joint statistician with Professor
Richard Peto on COMMIT/CCS-2.
Professor Sir Richard Peto
Professor of Medical Statistics & Epidemiology at the
University of Oxford. In 1975, Professor Peto set up the CTSU of
which he and Rory Collins are now co-directors. His work has
included studies of the causes of cancer in general, and of the
effects of smoking in particular, and the establishment of
large-scale randomised trials of the treatment of heart disease,
stroke, cancer and a variety of other diseases. He has been
instrumental in introducing combined 'meta-analyses' of results
from related trials that achieve uniquely reliable assessment of
treatment effects. He was elected a Fellow of the Royal Society
of London in 1989, and was knighted (for services to epidemiology
and to cancer prevention) in 1999. Professor Peto is joint
statistician with Dr Hongchao Pan on COMMIT/CCS-2.
Professor Peter Sleight
Consultant physician/cardiologist in Oxford since 1964. Professor
Sleight retired from the British Heart Foundation Field Marshall
Alexander Chair of Vascular Medicine in 1994, but continues as an
honorary Consultant at the John Radcliffe Hospital. He is chair
of the Steering Committees of the ISIS trials and (with T. Meade)
of the HPS and SEARCH studies, and is co-chair of the HOPE study
group (with S. Yusuf and C. Anderson). He is immediate Past
President of the World Hypertension League and serves on data
monitoring committees for several clinical trials. With
colleagues at the University of Padua, his recent research has
been on the prognostic value of measures of heart rate
variability and the pathophysiological processes underlying
changes in patients prone to vascular disease. Professor Sleight
has been awarded the Galen Medal of the Society of Apothecaries
for his work in circulatory physiology and trials, the Mackenzie
medal of the British Cardiac Society, and the International
Aspirin Foundation Senior Award (with C. Baigent, R .Collins and
R. Peto).
Professor Jingxiang Xie
Professor of Cardiology in Fuwai Hospital, Chinese Academy of
Medical Sciences. Professor Xie studied in Belgium from 1988 to
1991 and is a member of the World Hypertension League. She
co-ordinated the major 'CAST' stroke trial in China, and has been
clinical co-ordinator of COMMIT/CCS-2 at the Beijing
co-ordinating centre since the beginning of the trial.
|
|||